KOCHI: George (name changed), was 55-years-old when he was diagnosed with fatty liver. Since he was a teetotaller, he did not ...

Last week, BioVie announced a significant milestone: a Notice of Allowance from the Japan Patent Office for its application regarding a novel liquid formulation of terlipressin. This formulation, ...

As one in three Indians gets diagnosed with non-alcoholic fatty liver, a look at how lifestyle choices can make a difference.

Scientists from the University of Leicester have discovered that tuberculosis disrupts glucose metabolism in the body.

Weiss highlighted a 2012 Cochrane Library review that examined research and found the drug is “reasonably safe” and prolongs ...

up to 261,895 new shares can be issued upon the exercise of 90,780 share options that are still outstanding under the 'Executive Share Options' plan for staff members and consultants of the Company, ...

Positive results from the MAESTRO-NASH OUTCOMES study could make resmetirom the first medication approved for patients with compensated NASH ...

Diagnosing antibody-mediated rejection in liver transplant recipients is hindered by a lack of biomarkers and co-occurrence ...

But doctors and paramedics said morphine was not administered directly to Ms Price's heart, but instead to her hand or wrist ...

Schistosomiasis is a neglected tropical disease that triggers specific immune responses in the body. Identifying those hidden ...

FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based ...

Gene-editing therapies—techniques that modify DNA to treat or prevent disease—have the potential to transform the field of ...